INVO Bioscience, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on January 4, 2021, regarding events occurring on December 28, 2020. The filing details the results of the Company's annual meeting of stockholders held on that date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
The primary material event reported is the outcome of the annual stockholder meeting. A quorum was established with 5,810,783 shares present out of 9,561,468 shares entitled to vote. Stockholders approved two proposals:
- Election of Directors: Six nominees were elected to the Board of Directors: Steven Shum, Dr. Kevin Doody, Trent Davis, Barbara Ryan, Jeffrey Segal, and Matthew Szot.
- Ratification of Auditors: Stockholders ratified the selection of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the vote tallies for the annual meeting.
Investor Verification Checklist
- Verify the tenure and background of the newly elected board members.
- Confirm the engagement letter and scope of work with the newly ratified auditor, M&K CPAS, PLLC.
- Review the Company's most recent 10-K or 10-Q filings for financial metrics absent from this 8-K.
- Monitor subsequent filings for any changes in corporate governance or executive leadership.